WS06.6 Effect of lumacaftor/ivacaftor on lung clearance index and exercise capacity among patients aged over 12 years with cystic fibrosis homozygous for F508del-CFTR

E. Hatziagorou, E. Kouroukli, M. Parisi, A. Kampouras, L. Nousia, J. Tsanakas
  • Journal of Cystic Fibrosis, June 2018, Elsevier
  • DOI: 10.1016/s1569-1993(18)30154-1

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Eleana Kouroukli